The Litmus Papers

Trial by Data Podcast: The Future of Wearables

Featuring Harpreet Rai, CEO of Oura Ring, and Dr. Sam Volchenboum

Wearables in Review: The Fitbit Versa 3

With a lower price point than the Sense, the Fitbit Versa 3 has a great range of features…

Wearables in Review: Ōura Ring

Ōura is a relatively new company that largely focuses on athletes and athletic performance. They are one…

Trial by Data Podcast: The Truth Behind Generic Drugs

Wearables in Review: Polar Vantage V2

Although Polar is a device maker focused primarily on fitness, many of the company’s devices…

Wearables in Review: Actigraph GT9X Link

Actigraph is a veteran wearable company that exclusively targets the clinical audience…

Wearables in Review: The Apple Watch Series 6

Overview

Trial by Data Podcast: Healthcare Needs a 10 Year Plan

Wearables in Review: The Fitbit Sense

The Sense is Fitbit’s most robust wearable yet. It’s a solid…

Trial by Data Podcast: Special Episode! Is There a Perfect Wearable Device?

What’s the Best Wearable Device for Clinical Trials?

Trial by Data Podcast: Creating the Manhattan Project for Clinical Research

Trial by Data Podcast: From Government to Academia, Where is Clinical Research Working?

Trial by Data Season Two Debut: How Coronavirus is Impacting Clinical Trials

Litmus Health Achieves HIPAA and FISMA Compliance for Real World Data Infrastructure

This morning, we were pleased to announce that Litmus Health underwent an extensive third-party assessment of the company’s security practices that deemed our infrastructure to be…

Dr. David Rubin Discusses Initial Results of Takeda-Sponsored and Litmus-Powered Research at DDW

Litmus Implements Sixgill Integrity for Continuous Auditability

We recently announced that Litmus is partnering with Sixgill, LLC, the leader in sensor data services for governing Internet of Everything (IoE) assets, to adopt Sixgill Integrity. This will provide clinicians and…

Trial by Data Season One Finale: Building the Engine for Clinical Innovation

Trial by Data: The Deep Dive on Wearables

Featuring Rob Wilson and Jeremy Wyatt of ActiGraph and Dr. Sam Volchenboum

Announcing: NIH Grant to Enhance Drug Development with Real World Data & Our Device Census Report

One of the questions we are asked most often is how real world data can work in a clinical trial.

Trial by Data: Making Novel Endpoints Mainstream

Trial by Data: Fixing the Patient Pipeline

Featuring Kyle Holen of AbbVie and Dr. Sam Volchenboum

Trial by Data: Accessibility and Innovation in Trial Participation

Trial by Data: Volume and Variety of Data

Featuring Chris Economos of PhysIQ and Dr. Sam Volchenboum